Atlas Trials

Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis

Clinical trial NCT00059449 · COMPLETED

Trial details

NCT number
NCT00059449
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Study type
OBSERVATIONAL
Necrotizing EnterocolitisPremature Birth
Enrollment
372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.